logo
Site Network

Menu

Source Legend
  • Human-provided

    Entered or confirmed by an authorized person.

  • Google

    Imported Google information.

  • Trial-derived

    Calculated or extracted directly from associated trial records.

  • AI-inferred

    A capability inferred from trial history.

  • AI-extracted

    An explicit statement extracted from an official source.

  • Public registry

    Information from a public registry.

  • Site record

    Information held in the site record.

Source: Site record. Fortis Memorial Research Institute: Oncology Department

Verified
+918860022554
Source: Site record.
http://www.fortishealthcare.com/india/hospitals-in-delhi-ncr/fortis-memorial-research-institute-gurgaon/oncology-clinical-speciality-208/doctors

Basic Information

Site Overview

Source: Human-provided.

Fortis Memorial Research Institute (FMRI), Gurugram is a leading quaternary-care healthcare centre and flagship hospital of the Fortis Healthcare network, located in Sector 44, Gurugram, Haryana, India. Accredited by JCI, NABH and NABL, FMRI provides advanced multidisciplinary care across specialties including medical oncology, haematology, radiation and surgical oncology, bone marrow transplant (BMT) and supportive care. Its Department of Medical Oncology & Haematology offers comprehensive cancer care — from chemotherapy, immunotherapy and targeted therapies to complex haematological treatments and stem cell transplants — supported by cutting-edge technology and a team of experienced oncologists and specialists. The hospital’s integrated approach ensures personalised treatment plans tailored to each patient’s needs, backed by innovative diagnostics and clinical expertise. FMRI also houses centres of excellence in robotics, transplants and critical care, making it a major referral…

Source: Trial-derived.
11Total Trials
Source: Trial-derived.
1Recruiting Trials
Source: Trial-derived.
5Active Trials
Source: Trial-derived.
5Completed Trials
Source: Trial-derived.
8Unique Conditions
Source: Trial-derived.
10Unique Sponsors

Affiliations

Conditions

Source: Trial-derived. Ulcerative Colitis (5)Source: Trial-derived. Acute Myeloid Leukemia (1)Source: Trial-derived. Alopecia; X-Rays (1)Source: Trial-derived. Colitis, Ulcerative (1)Source: Trial-derived. Inflammatory Bowel Diseases (1)Source: Trial-derived. Multiple Sclerosis, Relapsing-Remitting (1)Source: Trial-derived. Paroxysmal Nocturnal Hemoglobinuria (1)Source: Trial-derived. Wegener's Granulomatosis or Microscopic Polyangiitis (1)

Sponsors

Source: Trial-derived. Abivax S.A. (2)Source: Trial-derived. Arena Pharmaceuticals (2)Source: Trial-derived. AbbVie (1)Source: Trial-derived. Arena is a wholly owned subsidiary of Pfizer (1)Source: Trial-derived. Fortis Memorial Research Institute (1)Source: Trial-derived. Hoffmann-La Roche (1)Source: Trial-derived. Immunic AG (1)Source: Trial-derived. Morphic Therapeutic, Inc. (A Wholly Owned Subsidiary of Eli Lilly and Company) (1)

Imaging & Diagnostics

Imaging and diagnostic capabilities inferred from trial participation

Source: AI-inferred. Electrocardiography (lead count not stated)

Laboratory & Biospecimens

Laboratory and biospecimen capabilities inferred from trial participation

Source: AI-inferred. Histology / pathology
Source: AI-inferred. Clinical laboratory testing
Source: AI-inferred. ELISA / immunoassay

Clinical Procedures

Clinical procedures inferred from trial participation

Source: AI-inferred. Endoscopy / colonoscopy

Accessibility & Parking

Accessibility Features

Source: Google. Wheelchair accessible entrance
Source: Google. Wheelchair accessible parking lot
Source: Google. Wheelchair accessible restroom

Amenities

Amenities Available

Source: Google. Restroom

Additional Capabilities

Other capabilities inferred from trial participation

Source: AI-inferred. Clostridium difficile toxin testing
Source: AI-inferred. Electronic patient-reported outcome (eDiary) system
Source: AI-inferred. Electronic patient-reported outcome (ePRO) diary system